Besides, comprehensive genomic analysis was performed in Rudin, Charles M., Nat Genet, 2012 (30), and it was concluded that SOX2 was a frequently amplified gene in SCLC, which laid a foundation for the precision therapy of SCLC. This evidence concerns the gene SOX2 and small cell lung carcinoma.